Equillium, Inc. (EQ)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Pharmaceuticals	36.08M	15.76M	-
Pharmaceuticals Growth	128.97%	-	-
Total	36.08M	15.76M	-
Total Growth	128.97%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
United States	36.08M	15.76M	-
United States Growth	128.97%	-	-
Total	36.08M	15.76M	-
Total Growth	128.97%	-	-

Source: S&P Global Market Intelligence.